We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
BMS’ Opdivo Wins Expanded Indications Indivior Receives FDA Complete Response Letter for Opioid Overdose Nasal Spray Aduro’s Mesothelioma Candidate Named Orphan Drug in EU EC Grants Expanded Indication to GSK’s PAH Drug Ackman Boosts Stock in Valeant to 9.9 Percent